Low high-density lipoprotein level is correlated with the severity of COVID-19 patients : an observational study
BACKGROUND: The purpose of the study is to describe the blood lipid levels of patients diagnosed with coronavirus disease 2019 (COVID-19) and to analyze the correlation between blood lipid levels and the prognosis of COVID-19 patients.
METHODS: In the clinical retrospective analysis, a total of 228 adults infected with COVID-19 were enrolled between January 17, 2020 and March 14, 2020, in Changsha, China. One thousand one hundred and forty healthy participants with matched age and gender were used as control. Median with interquartile range and Mann-Whitney test were adopted to describe and analyze clinical data. The Kaplan-Meier (KM) curve and Cox regression analysis were used to analyze the correlation between high-density lipoprotein cholesterol (HDL-C) and the severity of COVID-19.
RESULTS: Compared with control, COVID-19 patients showed significantly lower levels of total cholesterol (TC) [median, 3.76 vs 4.65 mmol/L, P = 0.031], triglyceride [median, 1.08 vs 1.21 mmol/L, P < 0.001], low-density lipoprotein cholesterol (LDL-C) [median, 2.63 vs 2.83 mmol/L, P < 0.001], and HDL-C [median, 0.78 vs 1.37 mmol/L, P < 0.001], while compared with non-severe patients, severe COVID-19 patients only presented lower levels of HDL-C [median, 0.69 vs 0.79 mmol/L, P = 0.032]. In comparison with patients with high HDL-C, patients with low HDL-C showed a higher proportion of male (69.57% vs 45.60%, P = 0.004), higher levels of C-reactive protein (CRP) (median, 27.83 vs 12.56 mg/L, P < 0.001) and higher proportion of severe events (36.96% vs 14.84%, P = 0.001). Moreover, patients with low HDL-C at admission showed a higher risk of developing severe events compared with those with high HDL-C (Log Rank P = 0.009). After adjusting for age, gender and underlying diseases, they still had elevated possibility of developing severe cases than those with high HDL-C (HR 2.827, 95% CI 1.190-6.714, P = 0.019).
CONCLUSIONS: HDL-C level was lower in COVID-19 adult patients, and low HDL-C in COVID-19 patients was correlated with a higher risk of developing severe events.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Lipids in health and disease - 19(2020), 1 vom: 07. Sept., Seite 204 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Guyi [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 09.09.2020 Date Revised 18.12.2020 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12944-020-01382-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314654860 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314654860 | ||
003 | DE-627 | ||
005 | 20231225153210.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12944-020-01382-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1048.xml |
035 | |a (DE-627)NLM314654860 | ||
035 | |a (NLM)32892746 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Guyi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Low high-density lipoprotein level is correlated with the severity of COVID-19 patients |b an observational study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.09.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: The purpose of the study is to describe the blood lipid levels of patients diagnosed with coronavirus disease 2019 (COVID-19) and to analyze the correlation between blood lipid levels and the prognosis of COVID-19 patients | ||
520 | |a METHODS: In the clinical retrospective analysis, a total of 228 adults infected with COVID-19 were enrolled between January 17, 2020 and March 14, 2020, in Changsha, China. One thousand one hundred and forty healthy participants with matched age and gender were used as control. Median with interquartile range and Mann-Whitney test were adopted to describe and analyze clinical data. The Kaplan-Meier (KM) curve and Cox regression analysis were used to analyze the correlation between high-density lipoprotein cholesterol (HDL-C) and the severity of COVID-19 | ||
520 | |a RESULTS: Compared with control, COVID-19 patients showed significantly lower levels of total cholesterol (TC) [median, 3.76 vs 4.65 mmol/L, P = 0.031], triglyceride [median, 1.08 vs 1.21 mmol/L, P < 0.001], low-density lipoprotein cholesterol (LDL-C) [median, 2.63 vs 2.83 mmol/L, P < 0.001], and HDL-C [median, 0.78 vs 1.37 mmol/L, P < 0.001], while compared with non-severe patients, severe COVID-19 patients only presented lower levels of HDL-C [median, 0.69 vs 0.79 mmol/L, P = 0.032]. In comparison with patients with high HDL-C, patients with low HDL-C showed a higher proportion of male (69.57% vs 45.60%, P = 0.004), higher levels of C-reactive protein (CRP) (median, 27.83 vs 12.56 mg/L, P < 0.001) and higher proportion of severe events (36.96% vs 14.84%, P = 0.001). Moreover, patients with low HDL-C at admission showed a higher risk of developing severe events compared with those with high HDL-C (Log Rank P = 0.009). After adjusting for age, gender and underlying diseases, they still had elevated possibility of developing severe cases than those with high HDL-C (HR 2.827, 95% CI 1.190-6.714, P = 0.019) | ||
520 | |a CONCLUSIONS: HDL-C level was lower in COVID-19 adult patients, and low HDL-C in COVID-19 patients was correlated with a higher risk of developing severe events | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Adult | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a High-density lipoprotein cholesterol | |
650 | 4 | |a Lipoproteins | |
650 | 4 | |a Prognosis | |
650 | 4 | |a Severe acute respiratory syndrome coronavirus 2 | |
650 | 7 | |a Cholesterol, HDL |2 NLM | |
650 | 7 | |a Cholesterol, LDL |2 NLM | |
650 | 7 | |a Triglycerides |2 NLM | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
650 | 7 | |a Cholesterol |2 NLM | |
650 | 7 | |a 97C5T2UQ7J |2 NLM | |
700 | 1 | |a Zhang, Quan |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Xianmei |e verfasserin |4 aut | |
700 | 1 | |a Dong, Haiyun |e verfasserin |4 aut | |
700 | 1 | |a Wu, Chenfang |e verfasserin |4 aut | |
700 | 1 | |a Wu, Fang |e verfasserin |4 aut | |
700 | 1 | |a Yu, Bo |e verfasserin |4 aut | |
700 | 1 | |a Lv, Jianlei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Siye |e verfasserin |4 aut | |
700 | 1 | |a Wu, Guobao |e verfasserin |4 aut | |
700 | 1 | |a Wu, Shangjie |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xiaolei |e verfasserin |4 aut | |
700 | 1 | |a Wu, Ying |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Yanjun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Lipids in health and disease |d 2002 |g 19(2020), 1 vom: 07. Sept., Seite 204 |w (DE-627)NLM123930782 |x 1476-511X |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2020 |g number:1 |g day:07 |g month:09 |g pages:204 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12944-020-01382-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2020 |e 1 |b 07 |c 09 |h 204 |